KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Total Liabilities (2019 - 2025)

Historic Total Liabilities for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $724.8 million.

  • GoodRx Holdings' Total Liabilities rose 1008.23% to $724.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $724.8 million, marking a year-over-year increase of 1008.23%. This contributed to the annual value of $663.4 million for FY2024, which is 1976.59% down from last year.
  • Latest data reveals that GoodRx Holdings reported Total Liabilities of $724.8 million as of Q3 2025, which was up 1008.23% from $675.7 million recorded in Q2 2025.
  • GoodRx Holdings' Total Liabilities' 5-year high stood at $826.8 million during Q4 2023, with a 5-year trough of $640.9 million in Q1 2025.
  • In the last 5 years, GoodRx Holdings' Total Liabilities had a median value of $774.1 million in 2022 and averaged $757.3 million.
  • Per our database at Business Quant, GoodRx Holdings' Total Liabilities crashed by 2792.02% in 2021 and then surged by 1008.23% in 2025.
  • GoodRx Holdings' Total Liabilities (Quarter) stood at $775.9 million in 2021, then grew by 1.79% to $789.8 million in 2022, then grew by 4.69% to $826.8 million in 2023, then dropped by 19.77% to $663.4 million in 2024, then grew by 9.25% to $724.8 million in 2025.
  • Its Total Liabilities was $724.8 million in Q3 2025, compared to $675.7 million in Q2 2025 and $640.9 million in Q1 2025.